News

Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

2 years ago

CitiusTech Launches Healthcare’s First End-to-End Generative AI Quality & Trust Solution

PRINCETON, N.J.--(BUSINESS WIRE)--#CitiusTech--CitiusTech, a leading provider of healthcare technology services and solutions, announced that it has launched an industry-first solution…

2 years ago

CitiusTech Launches Healthcare’s First End-to-End Generative AI Quality & Trust Solution

PRINCETON, N.J.--(BUSINESS WIRE)--#CitiusTech--CitiusTech, a leading provider of healthcare technology services and solutions, announced that it has launched an industry-first solution…

2 years ago

New Missouri Rural Health Program Directs Resources to Rural Communities to Improve Social Care Outcomes

The Missouri HealthNet Division introduces a new care model that utilizes the Unite Us Payments solution to create sustainability for…

2 years ago

New Missouri Rural Health Program Directs Resources to Rural Communities to Improve Social Care Outcomes

The Missouri HealthNet Division introduces a new care model that utilizes the Unite Us Payments solution to create sustainability for…

2 years ago

Scryb Announces Development of New Enterprise AI Venture

Toronto, Ontario--(Newsfile Corp. - February 14, 2024) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company") is pleased…

2 years ago

Unveiling Fortifeye Rejuvenate Collagen

A Groundbreaking Formula for Health and VitalityOCALA, FL / ACCESSWIRE / February 14, 2024 / Fortifeye Vitamins, a leading provider…

2 years ago

Unveiling Fortifeye Rejuvenate Collagen

A Groundbreaking Formula for Health and VitalityOCALA, FL / ACCESSWIRE / February 14, 2024 / Fortifeye Vitamins, a leading provider…

2 years ago

Skinvisible Announces Significant Progress in Licensee’s Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome

LAS VEGAS, NV / ACCESSWIRE / February 14, 2024 / Skinvisible, Inc. ("Skinvisible") (OTCQB:SKVI) is excited to share a promising…

2 years ago

Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services

KNOXVILLE, TN, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that…

2 years ago